Cargando…

Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis

BACKGROUND: Several randomized controlled trials (RCTs) have evaluated the efficacy of complete vs culprit-only revascularization for treatment of ST-segment elevation myocardial infarction (STEMI) with multivessel disease. However, the efficacy of complete revascularization vs culprit-only revascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lu-Feng, Qiu, Mei, Liu, Shu-Yan, Zhou, Hai-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238282/
https://www.ncbi.nlm.nih.gov/pubmed/34160388
http://dx.doi.org/10.1097/MD.0000000000026251
_version_ 1783714872040620032
author Li, Lu-Feng
Qiu, Mei
Liu, Shu-Yan
Zhou, Hai-Rong
author_facet Li, Lu-Feng
Qiu, Mei
Liu, Shu-Yan
Zhou, Hai-Rong
author_sort Li, Lu-Feng
collection PubMed
description BACKGROUND: Several randomized controlled trials (RCTs) have evaluated the efficacy of complete vs culprit-only revascularization for treatment of ST-segment elevation myocardial infarction (STEMI) with multivessel disease. However, the efficacy of complete revascularization vs culprit-only revascularization in some STEMI patient subgroups remains unclear. METHODS: We searched PubMed and Embase for related RCTs from the start date of databases to January 3, 2020. The endpoint assessed in this meta-analysis was major adverse cardiac events (MACE). Random-effects meta-analysis was conducted stratified by each of the 5 factors of interest (i.e., sex, age, history of diabetes, ECG infarct location, and the number of arteries with stenosis) to estimate pooled hazard ratio and 95% confidence interval. Random-effects meta-regression was conducted to assess subgroup differences. We examined publication bias by drawing funnel plots and performing Egger test. This meta-analysis is reported according to the PRISMA statement. RESULTS: Six RCTs were included for pooled analysis. Compared with culprit-only revascularization, complete revascularization significantly reduced the risk of MACE (hazard ratio 0.48, 95% confidence interval 0.42–0.55; I(2) = 0%; P for relative effect < .001). This significant reduction in the risk of MACE exhibited by complete revascularization was observed in most of the subgroups of interest. All of the subgroup effects based on the 5 factors of interest were not statistically significant (P(subgroup) ranged from 0.198 to 0.556). Publication bias was not suggested by funnel plots and Egger test. CONCLUSIONS: Compared with culprit-only revascularization, complete revascularization significantly reduces the MACE risk in patients with STEMI and multivessel disease, which is independent of sex, age, history of diabetes, ECG infarct location, and the number of arteries with stenosis.
format Online
Article
Text
id pubmed-8238282
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82382822021-07-06 Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis Li, Lu-Feng Qiu, Mei Liu, Shu-Yan Zhou, Hai-Rong Medicine (Baltimore) 3400 BACKGROUND: Several randomized controlled trials (RCTs) have evaluated the efficacy of complete vs culprit-only revascularization for treatment of ST-segment elevation myocardial infarction (STEMI) with multivessel disease. However, the efficacy of complete revascularization vs culprit-only revascularization in some STEMI patient subgroups remains unclear. METHODS: We searched PubMed and Embase for related RCTs from the start date of databases to January 3, 2020. The endpoint assessed in this meta-analysis was major adverse cardiac events (MACE). Random-effects meta-analysis was conducted stratified by each of the 5 factors of interest (i.e., sex, age, history of diabetes, ECG infarct location, and the number of arteries with stenosis) to estimate pooled hazard ratio and 95% confidence interval. Random-effects meta-regression was conducted to assess subgroup differences. We examined publication bias by drawing funnel plots and performing Egger test. This meta-analysis is reported according to the PRISMA statement. RESULTS: Six RCTs were included for pooled analysis. Compared with culprit-only revascularization, complete revascularization significantly reduced the risk of MACE (hazard ratio 0.48, 95% confidence interval 0.42–0.55; I(2) = 0%; P for relative effect < .001). This significant reduction in the risk of MACE exhibited by complete revascularization was observed in most of the subgroups of interest. All of the subgroup effects based on the 5 factors of interest were not statistically significant (P(subgroup) ranged from 0.198 to 0.556). Publication bias was not suggested by funnel plots and Egger test. CONCLUSIONS: Compared with culprit-only revascularization, complete revascularization significantly reduces the MACE risk in patients with STEMI and multivessel disease, which is independent of sex, age, history of diabetes, ECG infarct location, and the number of arteries with stenosis. Lippincott Williams & Wilkins 2021-06-25 /pmc/articles/PMC8238282/ /pubmed/34160388 http://dx.doi.org/10.1097/MD.0000000000026251 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 3400
Li, Lu-Feng
Qiu, Mei
Liu, Shu-Yan
Zhou, Hai-Rong
Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis
title Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis
title_full Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis
title_fullStr Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis
title_full_unstemmed Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis
title_short Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis
title_sort effects of patient characteristics on the efficacy of complete revascularization for treatment of st-segment elevation myocardial infarction with multivessel disease: a meta-analysis
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238282/
https://www.ncbi.nlm.nih.gov/pubmed/34160388
http://dx.doi.org/10.1097/MD.0000000000026251
work_keys_str_mv AT lilufeng effectsofpatientcharacteristicsontheefficacyofcompleterevascularizationfortreatmentofstsegmentelevationmyocardialinfarctionwithmultivesseldiseaseametaanalysis
AT qiumei effectsofpatientcharacteristicsontheefficacyofcompleterevascularizationfortreatmentofstsegmentelevationmyocardialinfarctionwithmultivesseldiseaseametaanalysis
AT liushuyan effectsofpatientcharacteristicsontheefficacyofcompleterevascularizationfortreatmentofstsegmentelevationmyocardialinfarctionwithmultivesseldiseaseametaanalysis
AT zhouhairong effectsofpatientcharacteristicsontheefficacyofcompleterevascularizationfortreatmentofstsegmentelevationmyocardialinfarctionwithmultivesseldiseaseametaanalysis